Sandborn WJ - Search Results

1

A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research.

Samaan MA, Mosli MH, Sandborn WJ, Feagan BG, DʼHaens GR, Dubcenco E, Baker KA, Levesque BG. Samaan MA, et al. Among authors: sandborn wj. Inflamm Bowel Dis. 2014 Aug;20(8):1465-71. doi: 10.1097/MIB.0000000000000046. Inflamm Bowel Dis. 2014. PMID: 24831558 Review.

2

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. Gasche C, et al. Among authors: sandborn wj. Inflamm Bowel Dis. 2000 Feb;6(1):8-15. doi: 10.1097/00054725-200002000-00002. Inflamm Bowel Dis. 2000. PMID: 10701144

3

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF, Sutherland LR. Sandborn WJ, et al. Gastroenterology. 2002 Feb;122(2):512-30. doi: 10.1053/gast.2002.31072. Gastroenterology. 2002. PMID: 11832465 Review. No abstract available.

4

The effectiveness of budesonide therapy for Crohn's disease.

Kane SV, Schoenfeld P, Sandborn WJ, Tremaine W, Hofer T, Feagan BG. Kane SV, et al. Among authors: sandborn wj. Aliment Pharmacol Ther. 2002 Aug;16(8):1509-17. doi: 10.1046/j.1365-2036.2002.01289.x. Aliment Pharmacol Ther. 2002. PMID: 12182751 Free article. Review.

5

Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?

Feagan BG, Sandborn WJ. Feagan BG, et al. Among authors: sandborn wj. Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15. Rev Gastroenterol Disord. 2002. PMID: 12478239 Review.

6

Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications.

Mahadevan U, Loftus EV Jr, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Mahadevan U, et al. Among authors: sandborn wj. Inflamm Bowel Dis. 2002 Sep;8(5):311-6. doi: 10.1097/00054725-200209000-00001. Inflamm Bowel Dis. 2002. PMID: 12479645

7

Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm.

Sandborn WJ, Feagan BG. Sandborn WJ, et al. Aliment Pharmacol Ther. 2003 Aug 1;18(3):263-77. doi: 10.1046/j.1365-2036.2003.01661.x. Aliment Pharmacol Ther. 2003. PMID: 12895211 Free article. Review.

8

AGA technical review on perianal Crohn's disease.

Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB; American Gastroenterological Association Clinical Practice Committee. Sandborn WJ, et al. Gastroenterology. 2003 Nov;125(5):1508-30. doi: 10.1016/j.gastro.2003.08.025. Gastroenterology. 2003. PMID: 14598268 Review. No abstract available.

9

CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial.

Sandborn WJ, Feagan BG, Radford-Smith G, Kovacs A, Enns R, Innes A, Patel J. Sandborn WJ, et al. Gut. 2004 Oct;53(10):1485-93. doi: 10.1136/gut.2003.035253. Gut. 2004. PMID: 15361500 Free PMC article. Clinical Trial.

10

The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain.

Sandborn WJ, Feagan BG. Sandborn WJ, et al. Gastroenterology. 2004 Sep;127(3):990-3. doi: 10.1053/j.gastro.2004.07.037. Gastroenterology. 2004. PMID: 15362055 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

948 results

Search Page